how long have glp 1 agonists been around GLP-1 Market Report 2025-2033, By Product, Molecule, and Geo Continued growth for GLP-1 receptor
Description
Sources for Figure 218
Mattioli Introduction GLP-1 agonists like liraglutide have become a powerful tool for weight management, but they often come with digestive side effects and concerns about long-term use
Not approved for diagnostic, therapeutic, or medical applications
The diabetes indication segment accounted for the largest share of the market
Nevertheless, the overall drug exposure was not considered clinically significant
Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy
